SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-027581
Filing Date
2017-05-15
Accepted
2017-05-15 16:57:33
Documents
4
Period of Report
2017-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v466986_8k.htm 8-K 17339
2 EXHIBIT 99.1 v466986_ex99-1.htm EX-99.1 65806
3 GRAPHIC image_001.jpg GRAPHIC 4049
4 GRAPHIC image_002.jpg GRAPHIC 8402
  Complete submission text file 0001144204-17-027581.txt   101721
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 17845329
SIC: 2834 Pharmaceutical Preparations